DOCE Researcher Ian Sweet, PhD, Receives NIH STTR Award

Dr. Ian Sweet has been awarded an NIH Small Business Technology Transfer (STTR) award for his project entitled ‘Continuous measurement of cell growth as an optimal tool in drug toxicity testing’. The NIH STTR program allows US-owned and operated small businesses to engage in federal research and development (R&D) that has a strong potential for commercialization. Dr. Sweet’s project aims to develop a systematic and ultra-sensitive in vitro approach for measuring drug toxicity. Dr. Sweet is an Associate Research Professor of Medicine in the Division of Metabolism, Endocrinology and Nutrition.